This chemical is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of bioactive compounds, particularly those targeting specific enzyme pathways. Its structure, featuring trifluoromethyl groups and a thioxomethylamino moiety, makes it valuable in the development of potent inhibitors for enzymes involved in inflammatory and metabolic disorders. Additionally, it is explored in medicinal chemistry for designing drug candidates with enhanced binding affinity and selectivity due to its unique steric and electronic properties. Research also indicates its potential application in the development of small molecule therapeutics for cancer and autoimmune diseases.